Published in BMC Nephrol on July 13, 2013
Liberation From Renal Replacement Therapy After Cadaveric Liver Transplantation. Transplant Direct (2016) 0.75
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl (2006) 2.55
Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant (2006) 2.53
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology (2007) 2.28
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl (2005) 1.87
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology (2010) 1.77
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int (2009) 1.76
Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation (1995) 1.63
Transplantation: impact of pretransplant renal insufficiency. Liver Transpl (2008) 1.58
Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg (1999) 1.54
Renal function outcomes following liver transplantation and combined liver-kidney transplantation. Nat Clin Pract Nephrol (2007) 1.52
Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl (2006) 1.49
Risk factors of acute renal failure after liver transplantation. Kidney Int (2006) 1.36
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2012) 1.30
Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant (2007) 1.22
Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract (2008) 1.20
Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl (2010) 1.14
Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl (2002) 1.12
Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant (1998) 1.11
Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience. Transplant Proc (2007) 1.02
The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant (2005) 1.02
Donor age and outcome of liver transplantation. Hepatology (1996) 0.96
Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth (2005) 0.96
Outcomes and native renal recovery following simultaneous liver-kidney transplantation. Am J Transplant (2012) 0.96
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant (2007) 0.92
Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation (2012) 0.91
Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg (2012) 0.89
Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Transplantation (2012) 0.89
Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis (2012) 0.87
Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant (2008) 0.86
Donor age as a predictor of risk for short-term outcomes after liver transplant. Exp Clin Transplant (2010) 0.83
Body surface area index predicts outcome in orthotopic liver transplantation. J Hepatobiliary Pancreat Sci (2011) 0.83
A new look at renal dysfunction in the cirrhotic patient. Crit Care (2012) 0.83
Perioperative use of continuous renal replacement therapy for orthotopic liver transplantation. Transplant Proc (2012) 0.83
Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury? Transplantation (2007) 0.82
Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc (2003) 0.80
Intensive care management of liver transplanted patients. World J Hepatol (2011) 0.79
Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era. Clin Transplant (2009) 0.78
Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age. Liver Transpl (2009) 0.78
Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury. HPB (Oxford) (2011) 0.77
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 16.24
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet (2008) 10.20
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet (2007) 7.85
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet (2012) 4.59
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res (2011) 4.22
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.29
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res (2010) 3.26
n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr (2010) 3.09
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry (2006) 3.01
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry (2012) 2.61
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry (2008) 2.53
Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull (2010) 2.50
The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum (2007) 2.25
The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol (2009) 2.05
Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol (2008) 2.02
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Decoding the massive genome of loblolly pine using haploid DNA and novel assembly strategies. Genome Biol (2014) 1.90
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry (2012) 1.85
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) (2005) 1.82
The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol (2011) 1.82
Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum (2007) 1.76
Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry (2007) 1.75
The choice of drugs for schizophrenia. N Engl J Med (2006) 1.75
In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A (2005) 1.72
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival. Clin Breast Cancer (2012) 1.67
Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol (2004) 1.58
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia. Am J Psychiatry (2002) 1.55
Evolution of genome size and complexity in Pinus. PLoS One (2009) 1.52
The use of depot medications in the treatment of schizophrenia. Am J Psychiatry (2010) 1.43
A dose finding study of weekly and every-3-week nab-Paclitaxel followed by carboplatin as first-line therapy in patients with advanced non-small cell lung cancer. J Thorac Oncol (2010) 1.40
Priming defense genes and metabolites in hybrid poplar by the green leaf volatile cis-3-hexenyl acetate. New Phytol (2008) 1.40
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res (2007) 1.34
Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology (2007) 1.34
Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 1.30
Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev (2012) 1.29
Specific recognition of apoptotic cells reveals a ubiquitous and unconventional innate immunity. J Biol Chem (2006) 1.25
Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology (2012) 1.21
Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis. J Biol Chem (2003) 1.20
Cardiolipin binds to CD1d and stimulates CD1d-restricted γδ T cells in the normal murine repertoire. J Immunol (2011) 1.19
S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport (2007) 1.17
High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology (2009) 1.16
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas. Clin Schizophr Relat Psychoses (2012) 1.12
Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis (2003) 1.12
Mammalian target of rapamycin and the kidney. I. The signaling pathway. Am J Physiol Renal Physiol (2012) 1.11
Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis. Biol Psychiatry (2010) 1.11
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder. Schizophr Res (2009) 1.11
Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull (2014) 1.11
Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications. Am J Physiol Renal Physiol (2012) 1.07
All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis. J Clin Psychopharmacol (2007) 1.07
The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells. J Biol Chem (2005) 1.06
Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol (2010) 1.04
Transcript profiles of the cytokinin response regulator gene family in Populus imply diverse roles in plant development. New Phytol (2007) 1.03
Performance of a self-report measure of the level of response to alcohol in 12- to 13-year-old adolescents. J Stud Alcohol (2005) 1.02
The cytokinin type-B response regulator PtRR13 is a negative regulator of adventitious root development in Populus. Plant Physiol (2009) 1.02
The antiphospholipid syndrome. Semin Nephrol (2007) 1.01
Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis (2010) 1.01
Cytokine dysregulation induced by apoptotic cells is a shared characteristic of macrophages from nonobese diabetic and systemic lupus erythematosus-prone mice. J Immunol (2004) 1.01
Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation (2006) 1.01
Association mapping of quantitative disease resistance in a natural population of loblolly pine (Pinus taeda L.). Genetics (2010) 1.00
MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacol (2011) 1.00
Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids (2009) 1.00
Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep (2010) 1.00
Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol (2011) 0.99
Whole-exome targeted sequencing of the uncharacterized pine genome. Plant J (2013) 0.99
Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev (2006) 0.99
Nonflowering plants possess a unique folate-dependent phenylalanine hydroxylase that is localized in chloroplasts. Plant Cell (2010) 0.99
The performance of elements of a 'level of response to alcohol'-based model of drinking behaviors in 13-year-olds. Addiction (2008) 0.98
Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl Acad Sci U S A (2010) 0.97
Genetic dissection of fusiform rust and pitch canker disease traits in loblolly pine. Theor Appl Genet (2005) 0.95
Testing a level of response to alcohol-based model of heavy drinking and alcohol problems in 1,905 17-year-olds. Alcohol Clin Exp Res (2011) 0.95
Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem (2003) 0.95
Evolution and diversity of invertase genes in Populus trichocarpa. Planta (2007) 0.94
The affirmative response of the innate immune system to apoptotic cells. Autoimmunity (2007) 0.94
First- and second-generation antipsychotics: learning from CUtLASS and CATIE. Arch Gen Psychiatry (2007) 0.94
Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study. J Clin Psychopharmacol (2003) 0.93
Comparative analysis of the transcriptomes of Populus trichocarpa and Arabidopsis thaliana suggests extensive evolution of gene expression regulation in angiosperms. New Phytol (2008) 0.92
The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull (2002) 0.92
IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. PLoS One (2010) 0.91
Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophr Bull (2008) 0.91
An evaluation of the performance of the self-rating of the effects of alcohol questionnaire in 12- and 35-year-old subjects. J Stud Alcohol (2006) 0.91
A high-density gene map of loblolly pine (Pinus taeda L.) based on exome sequence capture genotyping. G3 (Bethesda) (2014) 0.91
Efficiency of gene silencing in Arabidopsis: direct inverted repeats vs. transitive RNAi vectors. Plant Biotechnol J (2007) 0.90
Nab-paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis. Breast Cancer Res Treat (2013) 0.90
Abnormal regulation of the cytoskeletal regulator Rho typifies macrophages of the major murine models of spontaneous autoimmunity. J Leukoc Biol (2005) 0.90
Olfactory discrimination training up-regulates and reorganizes expression of microRNAs in adult mouse hippocampus. ASN Neuro (2010) 0.90
AMPK protects proximal tubular cells from stress-induced apoptosis by an ATP-independent mechanism: potential role of Akt activation. Am J Physiol Renal Physiol (2011) 0.90
The PANSS should be rescaled. Schizophr Bull (2010) 0.90
Macrophages from lupus-prone MRL mice are characterized by abnormalities in Rho activity, cytoskeletal organization, and adhesiveness to extracellular matrix proteins. J Leukoc Biol (2004) 0.89
Is the superior efficacy of new generation antipsychotics an artifact of LOCF? Schizophr Bull (2006) 0.89
Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia. J Clin Psychiatry (2006) 0.89
Association genetics of oleoresin flow in loblolly pine: discovering genes and predicting phenotype for improved resistance to bark beetles and bioenergy potential. New Phytol (2013) 0.88
Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect? J Rheumatol (2005) 0.88